-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Liminatus Pharma, Inc. quarterly Assets, Current history and change rate from Q4 2024 to Q3 2025.
- Liminatus Pharma, Inc. Assets, Current for the quarter ending 30 Sep 2025 was $1.2M.